BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 4, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Regulatory actions for March 16, 2026

March 16, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aminex, GSK, Mineralys.
Read More

Other news to note for March 16, 2026

March 16, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AMC Robotics, Aptar, Firefly, Geovax, Hive Digital, Inovio, Insulet, Intuitive Surgical, Koelis, Oncopeptides, Pfizer, Prism, Receptor.AI, Vistagen.
Read More

In the clinic for March 16, 2026

March 16, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Beren, Immutep, Insight Molecular, Sana, Ultragenyx.
Read More

Financings for March 16, 2026

March 16, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Cinclus, Equillium, Indivior, Novonesis, Xcath.
Read More

Appointments and advancements for March 16, 2026

March 16, 2026
New hires and promotions in the biopharma and med-tech industries, including: Eclinical, Koru Medical, Ratio.
Read More

Biggest gainers and losers for March 9-13, 2026

March 16, 2026
The top 10 biopharma stock gainers and losers for the week.
Read More

Biopharma money raised: Jan. 1-March 13, 2026

March 13, 2026
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More

Money raised by biopharma

March 13, 2026
Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.
Read More

Regulatory actions for March 13, 2026

March 13, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Atara, Johnson & Johnson, Pierre, Toro, Ultragreen, Xspray.
Read More

Other news to note for March 13, 2026

March 13, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Biomarin, Beaubrain, C2N, Circle, Eli Lilly, Enodia, Gyre, Kezar, Trinity, Zuellig.
Read More
Previous 1 2 … 19 20 21 22 23 24 25 26 27 … 1789 1790 Next

Popular Stories

  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • Alceptor Therapeutics discovers new α2B-adrenoceptor agonists

    BioWorld Science
    Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
  • Glucagon-like peptide-1 receptor (GLP-1R) complex

    Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control

    BioWorld
    A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing